DK0737686T3 - Camthothecinderivat med antitumoraktivitet - Google Patents
Camthothecinderivat med antitumoraktivitetInfo
- Publication number
- DK0737686T3 DK0737686T3 DK96105661T DK96105661T DK0737686T3 DK 0737686 T3 DK0737686 T3 DK 0737686T3 DK 96105661 T DK96105661 T DK 96105661T DK 96105661 T DK96105661 T DK 96105661T DK 0737686 T3 DK0737686 T3 DK 0737686T3
- Authority
- DK
- Denmark
- Prior art keywords
- compound
- camthothecin
- derivatives
- antitumor activity
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8371795 | 1995-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0737686T3 true DK0737686T3 (da) | 1999-11-22 |
Family
ID=13810270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96105661T DK0737686T3 (da) | 1995-04-10 | 1996-04-10 | Camthothecinderivat med antitumoraktivitet |
Country Status (13)
Country | Link |
---|---|
US (2) | US6504029B1 (da) |
EP (1) | EP0737686B1 (da) |
KR (1) | KR100400941B1 (da) |
CN (1) | CN1050131C (da) |
AT (1) | ATE181919T1 (da) |
CA (1) | CA2173671A1 (da) |
DE (1) | DE69603117T2 (da) |
DK (1) | DK0737686T3 (da) |
EA (1) | EA000036B1 (da) |
ES (1) | ES2136338T3 (da) |
GR (1) | GR3031400T3 (da) |
NO (1) | NO314085B1 (da) |
TW (1) | TW382630B (da) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ298259B6 (cs) | 2000-02-28 | 2007-08-08 | Aventis Pharma S. A. | Farmaceutická kombinace k lécení rakoviny obsahující CPT-11 a capecitabin |
US6545010B2 (en) | 2000-03-17 | 2003-04-08 | Aventis Pharma S.A. | Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer |
US6548488B2 (en) | 2000-03-17 | 2003-04-15 | Aventis Pharma S.A. | Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |
AR030207A1 (es) * | 2000-04-07 | 2003-08-13 | Daiichi Seiyaku Co | Composicion farmaceutica que contiene un derivado de camptotecina y procedimiento de preparacion de la misma |
US6486320B2 (en) | 2000-09-15 | 2002-11-26 | Aventis Pharma S.A. | Preparation of camptothecin and of its derivatives |
JP2004517821A (ja) | 2000-10-27 | 2004-06-17 | アベンティス・ファーマ・ソシエテ・アノニム | 癌治療のためのカンプトセシン及びスチルベン誘導体からなる組合せ |
US20090104254A1 (en) | 2004-12-22 | 2009-04-23 | Rutgers, The State University Of New Jersey | Controlled Release Hydrogels |
WO2012050591A1 (en) | 2010-10-15 | 2012-04-19 | Rutgers, The State University Of New Jersey | Hydrogel formulation for dermal and ocular delivery |
AU2007232206B2 (en) | 2006-03-30 | 2013-04-04 | Drais Pharmaceuticals, Inc. | Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
NZ593648A (en) | 2008-12-23 | 2013-09-27 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
EA201100851A1 (ru) | 2008-12-23 | 2012-04-30 | Фармассет, Инк. | Аналоги нуклеозидов |
CL2009002206A1 (es) | 2008-12-23 | 2011-08-26 | Gilead Pharmasset Llc | Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales. |
BR112012024884A2 (pt) | 2010-03-31 | 2016-10-18 | Gilead Pharmasset Llc | síntese estereosseletiva de ativos contendo fósforo |
KR102584005B1 (ko) | 2012-10-11 | 2023-09-27 | 다이이찌 산쿄 가부시키가이샤 | 글리신아미드 화합물의 제조 방법 |
JP6272230B2 (ja) | 2012-10-19 | 2018-01-31 | 第一三共株式会社 | 親水性構造を含むリンカーで結合させた抗体−薬物コンジュゲート |
RU2743077C2 (ru) | 2013-12-25 | 2021-02-15 | Дайити Санкио Компани, Лимитед | Конъюгат анти-trop2 антитело-лекарственное средство |
CN105829346B (zh) | 2014-01-31 | 2019-08-23 | 第一三共株式会社 | 抗her2抗体-药物偶联物 |
ES2859648T3 (es) | 2014-04-10 | 2021-10-04 | Daiichi Sankyo Co Ltd | Conjugado anticuerpo-fármaco anti-HER3 |
WO2015155976A1 (ja) | 2014-04-10 | 2015-10-15 | 第一三共株式会社 | 抗her2抗体-薬物コンジュゲート |
ES2938186T3 (es) | 2015-06-29 | 2023-04-05 | Daiichi Sankyo Co Ltd | Procedimiento de fabricación selectiva de un conjugado anticuerpo-fármaco |
CA3046293A1 (en) | 2016-12-12 | 2018-06-21 | Daiichi Sankyo Company, Limited | Combination of antibody-drug conjugate and immune checkpoint inhibitor |
EP3572428A4 (en) | 2017-01-17 | 2020-12-30 | Daiichi Sankyo Company, Limited | ANTI-GPR20 ANTIBODY AND ANTI-GPR20 ANTIBODY MEDICINAL CONJUGATE |
TW202330036A (zh) | 2017-05-15 | 2023-08-01 | 日商第一三共股份有限公司 | 抗體-藥物結合物之製造方法 |
WO2019044947A1 (ja) | 2017-08-31 | 2019-03-07 | 第一三共株式会社 | 抗体-薬物コンジュゲートの改良製造方法 |
CN117838881A (zh) * | 2017-08-31 | 2024-04-09 | 第一三共株式会社 | 制备抗体-药物缀合物的新方法 |
EP4257611A3 (en) | 2018-05-18 | 2024-03-06 | Glycotope GmbH | Anti-muc1 antibody |
CN112512591A (zh) | 2018-09-26 | 2021-03-16 | 江苏恒瑞医药股份有限公司 | 依喜替康类似物的配体-药物偶联物及其制备方法和应用 |
JP7408646B2 (ja) | 2018-09-30 | 2024-01-05 | ジエンス ハンソー ファーマスーティカル グループ カンパニー リミテッド | 抗-b7h3抗体-エキサテカンアナログコンジュゲート及びその医薬用途 |
PT3946464T (pt) | 2019-03-29 | 2022-11-16 | Medimmune Ltd | Compostos e seus conjugados |
KR20220052918A (ko) | 2019-07-10 | 2022-04-28 | 싸이브렉사 2, 인크. | 치료제로서의 사이토톡신의 펩티드 접합체 |
JP2022541747A (ja) | 2019-07-10 | 2022-09-27 | サイブレクサ 3,インコーポレイテッド | 治療薬としての微小管標的化剤のペプチドコンジュゲート |
WO2021115426A1 (zh) | 2019-12-12 | 2021-06-17 | 江苏恒瑞医药股份有限公司 | 抗密蛋白抗体药物偶联物及其医药用途 |
EP4095148A4 (en) | 2020-01-22 | 2023-07-26 | Jiangsu Hengrui Medicine Co., Ltd. | ANTI-TROP-2 ANTIBODY EXATECAN ANALOGUE CONJUGATE AND MEDICAL USE THEREOF |
TW202144016A (zh) | 2020-03-25 | 2021-12-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 抗psma抗體-依喜替康類似物偶聯物及其醫藥用途 |
JP2023518583A (ja) | 2020-03-25 | 2023-05-02 | 江蘇恒瑞医薬股▲ふん▼有限公司 | 抗体薬物複合体を含む医薬組成物及びその使用 本願は、2020年3月25日に提出された中国特許出願(出願番号cn 202010219601.7)及び2021年3月17日に提出された中国特許出願(出願番号cn 202110287012.7)の優先権を主張する。 |
MX2022011769A (es) | 2020-03-25 | 2022-10-18 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Metodo de preparacion de medicamento de conjugado de anticuerpo. |
WO2023030364A1 (zh) * | 2021-09-01 | 2023-03-09 | 上海弼领生物技术有限公司 | 一种喜树碱类化合物、其制备方法和用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6087746A (ja) * | 1983-10-17 | 1985-05-17 | Hakubakumai Kk | 即席麺ないしは焼そば用蒸し麺の製造方法 |
US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
US5637770A (en) * | 1991-01-16 | 1997-06-10 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic compound |
JP3359955B2 (ja) * | 1992-07-16 | 2002-12-24 | 第一製薬株式会社 | 抗腫瘍剤 |
IS4152A (is) * | 1993-04-29 | 1994-10-30 | Glaxo Inc. | Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra |
GB9319944D0 (en) * | 1993-09-28 | 1993-11-17 | Erba Carlo Spa | Process for the preparation of 9-amino camptothecin |
-
1995
- 1995-07-13 US US08/501,933 patent/US6504029B1/en not_active Expired - Fee Related
- 1995-09-18 CN CN95116111A patent/CN1050131C/zh not_active Expired - Fee Related
-
1996
- 1996-04-04 KR KR1019960010291A patent/KR100400941B1/ko not_active IP Right Cessation
- 1996-04-09 NO NO19961405A patent/NO314085B1/no unknown
- 1996-04-09 TW TW085104156A patent/TW382630B/zh not_active IP Right Cessation
- 1996-04-09 EA EA199600018A patent/EA000036B1/ru not_active IP Right Cessation
- 1996-04-09 CA CA002173671A patent/CA2173671A1/en not_active Abandoned
- 1996-04-10 DK DK96105661T patent/DK0737686T3/da active
- 1996-04-10 DE DE69603117T patent/DE69603117T2/de not_active Expired - Fee Related
- 1996-04-10 EP EP96105661A patent/EP0737686B1/en not_active Expired - Lifetime
- 1996-04-10 ES ES96105661T patent/ES2136338T3/es not_active Expired - Lifetime
- 1996-04-10 AT AT96105661T patent/ATE181919T1/de not_active IP Right Cessation
-
1999
- 1999-09-30 GR GR990402491T patent/GR3031400T3/el unknown
-
2001
- 2001-06-11 US US09/876,945 patent/US6552197B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EA199600018A3 (ru) | 1997-03-31 |
EP0737686A1 (en) | 1996-10-16 |
CN1050131C (zh) | 2000-03-08 |
KR960037682A (ko) | 1996-11-19 |
NO961405D0 (no) | 1996-04-09 |
ATE181919T1 (de) | 1999-07-15 |
EP0737686B1 (en) | 1999-07-07 |
US6504029B1 (en) | 2003-01-07 |
CA2173671A1 (en) | 1996-10-11 |
DE69603117D1 (de) | 1999-08-12 |
AU5056696A (en) | 1996-10-24 |
GR3031400T3 (en) | 2000-01-31 |
DE69603117T2 (de) | 1999-10-28 |
TW382630B (en) | 2000-02-21 |
AU692078B2 (en) | 1998-05-28 |
EA199600018A2 (ru) | 1996-10-01 |
EA000036B1 (ru) | 1998-02-26 |
KR100400941B1 (ko) | 2003-12-24 |
US6552197B2 (en) | 2003-04-22 |
NO961405L (no) | 1996-10-11 |
NO314085B1 (no) | 2003-01-27 |
US20010034446A1 (en) | 2001-10-25 |
ES2136338T3 (es) | 1999-11-16 |
CN1133290A (zh) | 1996-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0737686T3 (da) | Camthothecinderivat med antitumoraktivitet | |
DE69327567T2 (de) | Verfahren zur Herstellung von Alanylglutamin | |
FR2383907A1 (fr) | Procede de preparation de derives de l'acide acetique et derives obtenus par ce procede | |
NO882588L (no) | Fremgangsmaate ved fremstilling av substituerte inololinonderivater. | |
BG95145A (bg) | Метод за получаване на 9-заместени гуанинови производни | |
KR880700793A (ko) | 퀴놀린 카복실산의 제조 방법 | |
DE69809888T2 (de) | Verfahren zur Herstellung von alpha-Aminoketonen | |
DK159432C (da) | Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater | |
ATE18208T1 (de) | N-(4-hydroxyphenyl)essigsaeureamid-estern aus 5benzoyl-1-methylpyrrol-2-essigsaeure. | |
SE8503811D0 (sv) | Novel process for the preparation of an aminolactone | |
ATE57934T1 (de) | Verfahren zur herstellung von griseolinsaeurederivaten. | |
ES2104612T3 (es) | Procedimiento de preparacion de derivados de sulfonamida de norbornano. | |
ATE100105T1 (de) | Physiologisch aktive substanz fa-4283, derivate und ihre herstellung. |